Current and historical daily PE Ratio for AGE (
AgeX Therapeutics Inc
) from 2018 to Jun 07 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. AgeX Therapeutics stock (AGE) PE ratio as of Jun 07 2024 is 0.
More Details
AgeX Therapeutics Inc (AGE) PE Ratio (TTM) Chart
AgeX Therapeutics Inc (AGE) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1195
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| AgeX Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-07 | At Loss | 2024-01-23 | At Loss |
| 2024-03-26 | At Loss | 2024-01-22 | At Loss |
| 2024-03-25 | At Loss | 2024-01-19 | At Loss |
| 2024-03-22 | At Loss | 2024-01-18 | At Loss |
| 2024-03-21 | At Loss | 2024-01-17 | At Loss |
| 2024-03-20 | At Loss | 2024-01-16 | At Loss |
| 2024-03-19 | At Loss | 2024-01-12 | At Loss |
| 2024-03-18 | At Loss | 2024-01-11 | At Loss |
| 2024-03-15 | At Loss | 2024-01-10 | At Loss |
| 2024-03-14 | At Loss | 2024-01-09 | At Loss |
| 2024-03-13 | At Loss | 2024-01-08 | At Loss |
| 2024-03-12 | At Loss | 2024-01-05 | At Loss |
| 2024-03-11 | At Loss | 2024-01-04 | At Loss |
| 2024-03-08 | At Loss | 2024-01-03 | At Loss |
| 2024-03-07 | At Loss | 2024-01-02 | At Loss |
| 2024-03-06 | At Loss | 2023-12-29 | At Loss |
| 2024-03-05 | At Loss | 2023-12-28 | At Loss |
| 2024-03-04 | At Loss | 2023-12-27 | At Loss |
| 2024-03-01 | At Loss | 2023-12-26 | At Loss |
| 2024-02-29 | At Loss | 2023-12-22 | At Loss |
| 2024-02-28 | At Loss | 2023-12-21 | At Loss |
| 2024-02-27 | At Loss | 2023-12-20 | At Loss |
| 2024-02-26 | At Loss | 2023-12-19 | At Loss |
| 2024-02-23 | At Loss | 2023-12-18 | At Loss |
| 2024-02-22 | At Loss | 2023-12-15 | At Loss |
| 2024-02-21 | At Loss | 2023-12-14 | At Loss |
| 2024-02-20 | At Loss | 2023-12-13 | At Loss |
| 2024-02-16 | At Loss | 2023-12-12 | At Loss |
| 2024-02-15 | At Loss | 2023-12-11 | At Loss |
| 2024-02-14 | At Loss | 2023-12-08 | At Loss |
| 2024-02-13 | At Loss | 2023-12-07 | At Loss |
| 2024-02-12 | At Loss | 2023-12-06 | At Loss |
| 2024-02-09 | At Loss | 2023-12-05 | At Loss |
| 2024-02-08 | At Loss | 2023-12-04 | At Loss |
| 2024-02-07 | At Loss | 2023-12-01 | At Loss |
| 2024-02-06 | At Loss | 2023-11-30 | At Loss |
| 2024-02-05 | At Loss | 2023-11-29 | At Loss |
| 2024-02-02 | At Loss | 2023-11-28 | At Loss |
| 2024-02-01 | At Loss | 2023-11-27 | At Loss |
| 2024-01-31 | At Loss | 2023-11-24 | At Loss |
| 2024-01-30 | At Loss | 2023-11-22 | At Loss |
| 2024-01-29 | At Loss | 2023-11-21 | At Loss |
| 2024-01-26 | At Loss | 2023-11-20 | At Loss |
| 2024-01-25 | At Loss | 2023-11-17 | At Loss |
| 2024-01-24 | At Loss | 2023-11-16 | At Loss |
AgeX Therapeutics Inc (AGE) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
AgeX Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US00848H1086
Description
AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develops medicines designed to address some of the unsolved problems in aging. Its PureStem-derived cell-based therapeutic candidates in development are AGEX-VASC1, AGEX-BAT1 and AGEX-iTR1547.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers